
Skyrizi: Uses, Dosage, Side Effects and more Drugs.com
Nov 11, 2025 · Skyrizi (risankizumab) is an injection used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Includes indications, doses, interactions, side effects and more.
Learn more about SKYRIZI® (risankizumab‐rzaa)
SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light …
Skyrizi (risankizumab-rzaa) - Uses, Side Effects, and More
Aug 21, 2024 · Find patient medical information for Skyrizi (risankizumab-rzaa) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Skyrizi (Risankizumab-rzaa Injection): Side Effects, Uses ... - RxList
May 21, 2025 · Skyrizi (Risankizumab-rzaa Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …
Skyrizi: Psoriasis Uses, Side Effects, Warnings - MedicineNet
Jan 18, 2024 · Skyrizi is a prescription injection psoriasis medication used to treat adults with psoriasis, psoriatic arthritis, and Crohn's disease. Serious Skyrizi side effects include lowering the ability of your …
Skyrizi: Side effects, uses, dosage, cost, and more
Aug 8, 2025 · Skyrizi (risankizumab-rzaa) is a brand-name drug used for plaque psoriasis, Crohn’s disease, and other conditions. Learn about side effects, uses, and more.
DailyMed - SKYRIZI- risankizumab-rzaa kit SKYRIZI- risankizumab-rzaa ...
Sep 3, 2025 · SKYRIZI is contraindicated in patients with a history of serious hypersensitivity reaction to risankizumab-rzaa or any of the excipients [see Warnings and Precautions (5.1)].
Skyrizi (Risankizumab): Uses & Side Effects - Cleveland Clinic
Skyrizi (risankizumab) treats symptoms of psoriasis, psoriatic arthritis and Crohn's disease by reducing inflammation in your body.
SKYRIZI® (risankizumab-rzaa) HCP - Official Site by AbbVie Inc.
SKYRIZI® (risankizumab-rzaa) is contraindicated in patients with a history of serious hypersensitivity reaction to risankizumab-rzaa or any of the excipients. Serious hypersensitivity reactions, including …
Skyrizi Injection: Uses, Taking, Side Effects, Warnings - Medicine.com
Jun 28, 2022 · Skyrizi is an interleukin-23 antagonist used to treat psoriasis, psoriatic arthritis and Crohn's disease.